GFAP and central nervous system cancer: Recently, serum GFAP (sGFAP) was shown to be closely linked with glioma, but additional studies are necessary to fully explore the potential of sGFAP as a rapid tool for the diagnosis and follow-up of glioma and definite acting mechanism of GFAP in GBM [20].